Azome announces appointment of Ulrich H. Von Andrian, MD to Scientific Advisory Board

April 7, 2023

Azome Therapeutics, an early stage drug discovery company, announced the appointment of Ulrich H. Von Andrian, MD to its Scientific Advisory Board.  Dr. Von Andrian is the Edward Mallinckrodt Jr. Professor of Immunopathology, Microbiology and Immunobiology at Harvard Medical School, and Senior Investigator at the Von Andrian Lab at Boston Children's Hospital.